Intest Res.  2019 Jan;17(1):1-5. 10.5217/ir.2019.00005.

A new opportunity for innovative inflammatory bowel disease research: the moderate-to-severe ulcerative colitis in Korea (MOSAIK) cohort study

• Lee CK
• Lee KM
• Park DI
• Jung SA
• Jeen YT
• Park YS
• Kim HJ

• KMID: 2438436
• DOI: http://doi.org/10.5217/ir.2019.00005

Abstract

No abstract available.

MeSH Terms

Cohort Studies*
Colitis, Ulcerative*
Inflammatory Bowel Diseases*
Korea*
Ulcer*

Figure

• 

  Fig. 1. Schematic overview of study follow-up and evaluation. Enrollment visit (E) evaluation items: patient-reported outcomes, assessment by medical staff, laboratory tests, medical resource utilization records, specimen collection and storage; follow-up visit (A): assessment by medical staff, medical resource utilization records; follow-up visit (B): patient-reported outcomes, assessment by medical staff, laboratory tests, medical resource utilization records.

• 

  Fig. 2. Actual and targeted number of patients with active follow-up in 2018.

Reference

1. Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis. 2008; 14:542–549.

2. Kim HJ, Hann HJ, Hong SN, et al. Incidence and natural course of inflammatory bowel disease in Korea, 2006-2012: a nationwide population-based study. Inflamm Bowel Dis. 2015; 21:623–630.

3. Jung YS, Han M, Kim WH, Park S, Cheon JH. Incidence and clinical outcomes of inflammatory bowel disease in South Korea, 2011-2014: a nationwide population-based study. Dig Dis Sci. 2017; 62:2102–2112.

4. Kim JW, Lee CK, Rhee SY, Oh CH, Shim JJ, Kim HJ. Trends in health-care costs and utilization for inflammatory bowel disease from 2010 to 2014 in Korea: a nationwide populationbased study. J Gastroenterol Hepatol. 2018; 33:847–854.

5. Hoivik ML, Moum B, Solberg IC, et al. Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: results from the IBSEN study. Inflamm Bowel Dis. 2012; 18:1540–1549.

6. Bopanna S, Ananthakrishnan AN, Kedia S, Yajnik V, Ahuja V. Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017; 2:269–276.

7. Wanderås MH, Moum BA, Høivik ML, Hovde Ø. Predictive factors for a severe clinical course in ulcerative colitis: results from population-based studies. World J Gastrointest Pharmacol Ther. 2016; 7:235–241.

8. Lee JW, Im JP, Cheon JH, Kim YS, Kim JS, Han DS. Inflammatory bowel disease cohort studies in Korea: present and future. Intest Res. 2015; 13:213–218.

9. Shi HY, Levy AN, Trivedi HD, Chan FK, Ng SC, Ananthakrishnan AN. Ethnicity influences phenotype and outcomes in inflammatory bowel disease: a systematic review and meta-analysis of population-based studies. Clin Gastroenterol Hepatol. 2018; 16:190–197.

10. D’Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007; 132:763–786.